Molina Healthcare (MOH) Expected to Announce Quarterly Earnings on Wednesday

Molina Healthcare (NYSE:MOH - Get Free Report) is expected to announce its Q2 2025 earnings results after the market closes on Wednesday, July 23rd. Analysts expect the company to announce earnings of $6.12 per share and revenue of $10.94 billion for the quarter. Molina Healthcare has set its FY 2025 guidance at 24.500- EPS.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, beating analysts' consensus estimates of $5.96 by $0.12. The business had revenue of $11.15 billion during the quarter, compared to the consensus estimate of $10.86 billion. Molina Healthcare had a return on equity of 28.38% and a net margin of 2.81%. The business's quarterly revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the business earned $5.73 EPS. On average, analysts expect Molina Healthcare to post $24 EPS for the current fiscal year and $28 EPS for the next fiscal year.

Molina Healthcare Stock Performance

MOH traded down $10.09 during trading on Thursday, reaching $205.97. 904,883 shares of the company were exchanged, compared to its average volume of 723,629. The stock has a market cap of $11.16 billion, a P/E ratio of 9.92, a PEG ratio of 0.90 and a beta of 0.55. The firm has a 50 day moving average of $287.00 and a 200 day moving average of $301.64. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.87. Molina Healthcare has a 52 week low of $201.17 and a 52 week high of $365.23.

Insider Activity

In other news, Director Richard M. Schapiro sold 669 shares of the stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the transaction, the director owned 11,244 shares of the company's stock, valued at approximately $3,603,702. This represents a 5.62% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the sale, the chief executive officer owned 257,715 shares of the company's stock, valued at approximately $82,484,262.90. The trade was a 25.35% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company's stock.

Institutional Trading of Molina Healthcare

A number of hedge funds have recently modified their holdings of MOH. Goldman Sachs Group Inc. raised its holdings in shares of Molina Healthcare by 19.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company's stock worth $82,172,000 after buying an additional 40,531 shares in the last quarter. Woodline Partners LP acquired a new stake in Molina Healthcare during the 1st quarter valued at $1,541,000. Focus Partners Wealth increased its holdings in Molina Healthcare by 82.7% during the 1st quarter. Focus Partners Wealth now owns 3,749 shares of the company's stock valued at $1,235,000 after purchasing an additional 1,697 shares in the last quarter. Jones Financial Companies Lllp increased its holdings in Molina Healthcare by 713.3% during the 1st quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company's stock valued at $544,000 after purchasing an additional 1,448 shares in the last quarter. Finally, NewEdge Advisors LLC increased its holdings in Molina Healthcare by 33.4% during the 1st quarter. NewEdge Advisors LLC now owns 1,106 shares of the company's stock valued at $364,000 after purchasing an additional 277 shares in the last quarter. Institutional investors own 98.50% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Robert W. Baird reiterated a "neutral" rating and set a $375.00 price target (up previously from $331.00) on shares of Molina Healthcare in a research report on Tuesday, April 15th. Truist Financial cut their price objective on Molina Healthcare from $400.00 to $335.00 and set a "buy" rating for the company in a report on Wednesday. Wall Street Zen lowered Molina Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, June 29th. Mizuho set a $330.00 price objective on Molina Healthcare and gave the company an "outperform" rating in a report on Friday, July 11th. Finally, Sanford C. Bernstein initiated coverage on Molina Healthcare in a report on Tuesday, April 22nd. They issued an "outperform" rating and a $414.00 price objective for the company. Eleven research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $347.57.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.